actuatetherapeutics.com - Total Nilai Bisnis ACTU
The price trajectory of Actuate Therapeutics, Inc. (ACTU) reflects a scenario where the company is depleting reserves on clinical trials without current sales, while the Enterprise Value stands at 4.87. The business relies on alliances with oncology centers to accelerate the launch of elraglisib. Growth potential is based on patents, as the commercialization of new drugs will ensure a sharp surge in revenue with low production costs.
Ringkesan rincian data analitis Actuate Therapeutics, Inc. (ACTU)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Actuate Therapeutics, Inc.|ACTU - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal actuatetherapeutics.com|ACTU - Gunggung utang perusahaan|Utang marang nilai buku Actuate Therapeutics|ACTU - Utang jangka dawa perusahaan|Utang jangka cendhak Actuate Therapeutics|Rasio jangkoan perantara actuatetherapeutics.com
- data bathi bisnis lan rasio investasi:
Ringkesan analitik perusahaan:ACTU - Actuate Therapeutics Inc.
The enterprise value of Actuate Therapeutics, Inc. (ACTU) at 4.87 reflects the total cost of business acquisition, combining market capitalization and debt load minus liquid assets. By analyzing historical EV levels, an investor assesses the fundamental stability of this biopharmaceutical startup developing innovative GSK-3 beta inhibitors to combat resistant forms of oncology.
Karo sapa Actuate Therapeutics, Inc. saingan
ONC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|HALO: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Revolution Medicines Corp - Total Nilai Bisnis|AAPG (Ascentage Pharma Group) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|cgoncology.com (CGON) - Nilai Perusahaan|URGN (UroGen Pharma) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Bicara Therapeutics Inc (BCAX)|Nilai Perusahaan PSNL|Nilai Perusahaan Erasca Oncology (ERAS)|Nilai Total Perusahaan Delcath Systems, Inc. DCTH|YMAB: Nilai Bisnis|Aura Biosciences - Nilai Perusahaan|Candel Therapeutics (CADL) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|ARAY: Nilai Perusahaan|Total Nilai Perusahaan SELLAS Life Sciences Group (SLS)|Nilai Total Perusahaan Citius Oncology, Inc.|HURA: Nilai Dipunlarasaken Utang lan Kas|Rega Nyata Tumbas Perusahaan Kanthi Wutuh TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan WHWK (Aadi Bioscience)|TCRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|CSBR: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|XBIT - Nilai Perusahaan|cel-sci.com (CVM) - Nilai Total Perusahaan|OS Therapies Inc. - Nilai Dipunlarasaken Utang lan Kas|RADX (Radiopharm Theranostics) - Nilai Perusahaan|Total Nilai Perusahaan Artiva ARTV|Nilai Perusahaan ANL|Nilai Perusahaan verupharma.com (VERU)|Nilai Perusahaan TPST (Tempest Therapeutics, Inc.)|XLO - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|RENB: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Mural Oncology plc - Total Nilai Bisnis|KAPA (kairospharma.com) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|OnKure Therapeutics (OKUR) - Nilai Perusahaan|GDTC (CytoMed Therapeutics Ltd) - Nilai Perusahaan|Nilai Perusahaan Curis Corp|Rega Nyata Tumbas Perusahaan Kanthi Wutuh APLM (Apollomics, Inc.)|Total Nilai Bisnis THAR|Nilai Perusahaan ADVB (Advanced Biomed)|genprex.com (GNPX) - Total Nilai Perusahaan|CLDI: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas SBFM (sunshinebiopharma.com)|XBIO (xeneticbio.com) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|SLRX: Total Nilai Bisnis|PPBT (Purple Biotech) - Nilai Perusahaan|AONC: Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan BGNE|CKPT - Total Nilai Perusahaan|Nilai Total Perusahaan Elevation Oncology ELEV|Nilai Dipunlarasaken Utang lan Kas ICAD|Ikena - Nilai Perusahaan|NTBL - Nilai Perusahaan|viracta.com (VIRX) - Nilai Total Perusahaan|Nilai Wutuh Bisnis MOR (MorphoSys Inc)|NAYA (NAYA Bio) - Nilai Perusahaan|Total Nilai Perusahaan Ascentage AAPGV